The Mutebutton has been developed by Neuromod Devices that plans to create 50 jobs over the next five years in Dublin.
The company, based in NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin, is aiming to become a leading global provider of non-surgical neuromodulation treatments chronic conditions.
Mutebutton, its multi-sensory medical device, is a clinically proven, self-administered treatment designed to alleviate the symptoms of chronic tinnitus sufferers.
It is the culmination of over four years of research and development since the company was founded by its chief executive, Dr Ross O’Neill, as a spin-out from NUI Maynooth.
The device, plus the initial consultation, costs €2,500. It combines synchronous audio and lingual (tongue) stimulation to promote patient neuroplastticity, effectively retraining the brain.
About one in 10 adults in Britain have tinnitus, a figure that is likely to be mirrored in Ireland.
Tinnitus, a common condition is the medical name for the perception of noise in one ear, both ears, or in the head. The noise comes from inside the body rather than an outside source.
The Mutebutton is used for a minimum of 30 minutes a day over a 10 week period.
The treatment has been clinically proven to reduce the sounds associated with tinnitus in studies conducted by NUI Maynooth and the Hermitage Medical Centre in Dublin. When the device is purchased it is delivered to The Neuromod Clinic, based in the Hermitage Medical Centre, where patients will have the device configured to their needs by a qualified audiologist.
The Mutebutton will be on sale in Ireland from Monday.